These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16794189)

  • 1. Identification of sokotrasterol sulfate as a novel proangiogenic steroid.
    Murphy S; Larrivée B; Pollet I; Craig KS; Williams DE; Huang XH; Abbott M; Wong F; Curtis C; Conrads TP; Veenstra T; Puri M; Hsiang Y; Roberge M; Andersen RJ; Karsan A
    Circ Res; 2006 Aug; 99(3):257-65. PubMed ID: 16794189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor.
    Mousa SA; Bergh JJ; Dier E; Rebbaa A; O'Connor LJ; Yalcin M; Aljada A; Dyskin E; Davis FB; Lin HY; Davis PJ
    Angiogenesis; 2008; 11(2):183-90. PubMed ID: 18080776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
    Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
    Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small molecule approaches for promoting ischemic tissue vascularization.
    Bussolino F
    Circ Res; 2006 Aug; 99(3):231-3. PubMed ID: 16888247
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic angiogenesis of mouse hind limb ischemia by novel peptide activating GRP78 receptor on endothelial cells.
    Hardy B; Battler A; Weiss C; Kudasi O; Raiter A
    Biochem Pharmacol; 2008 Feb; 75(4):891-9. PubMed ID: 18022603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nerve growth factor (NGF) promotes angiogenesis in the quail chorioallantoic membrane.
    Lazarovici P; Gazit A; Staniszewska I; Marcinkiewicz C; Lelkes PI
    Endothelium; 2006; 13(1):51-9. PubMed ID: 16885067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists.
    Presta M; Oreste P; Zoppetti G; Belleri M; Tanghetti E; Leali D; Urbinati C; Bugatti A; Ronca R; Nicoli S; Moroni E; Stabile H; Camozzi M; Hernandez GA; Mitola S; Dell'Era P; Rusnati M; Ribatti D
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):71-6. PubMed ID: 15514208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia.
    Li Y; Hazarika S; Xie D; Pippen AM; Kontos CD; Annex BH
    Diabetes; 2007 Mar; 56(3):656-65. PubMed ID: 17327433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative proteomic analysis of sokotrasterol sulfate-stimulated primary human endothelial cells.
    Karsan A; Pollet I; Yu LR; Chan KC; Conrads TP; Lucas DA; Andersen R; Veenstra T
    Mol Cell Proteomics; 2005 Feb; 4(2):191-204. PubMed ID: 15611527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VEGF and inhibitors of TGFbeta type-I receptor kinase synergistically promote blood-vessel formation by inducing alpha5-integrin expression.
    Liu Z; Kobayashi K; van Dinther M; van Heiningen SH; Valdimarsdottir G; van Laar T; Scharpfenecker M; Löwik CW; Goumans MJ; Ten Dijke P; Pardali E
    J Cell Sci; 2009 Sep; 122(Pt 18):3294-302. PubMed ID: 19706683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha4beta1 integrin mediates selective endothelial cell responses to thrombospondins 1 and 2 in vitro and modulates angiogenesis in vivo.
    Calzada MJ; Zhou L; Sipes JM; Zhang J; Krutzsch HC; Iruela-Arispe ML; Annis DS; Mosher DF; Roberts DD
    Circ Res; 2004 Mar; 94(4):462-70. PubMed ID: 14699013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HoxB5 induces endothelial sprouting in vitro and modifies intussusceptive angiogenesis in vivo involving angiopoietin-2.
    Winnik S; Klinkert M; Kurz H; Zoeller C; Heinke J; Wu Y; Bode C; Patterson C; Moser M
    Cardiovasc Res; 2009 Aug; 83(3):558-65. PubMed ID: 19403561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the tyrosine phosphatase SHP-2 suppresses angiogenesis in vitro and in vivo.
    Mannell H; Hellwig N; Gloe T; Plank C; Sohn HY; Groesser L; Walzog B; Pohl U; Krotz F
    J Vasc Res; 2008; 45(2):153-63. PubMed ID: 17962719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pro-angiogenesis action of thyroid hormone and analogs in a three-dimensional in vitro microvascular endothelial sprouting model.
    Mousa SA; Davis FB; Mohamed S; Davis PJ; Feng X
    Int Angiol; 2006 Dec; 25(4):407-13. PubMed ID: 17164749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil-activating protein-2- and interleukin-8-mediated angiogenesis.
    Powell JA; Mousa SA
    J Cell Biochem; 2007 Oct; 102(2):412-20. PubMed ID: 17352409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenic response of endothelial cells to heparin-binding domain of fibronectin.
    Viji RI; Kumar VB; Kiran MS; Sudhakaran PR
    Int J Biochem Cell Biol; 2008; 40(2):215-26. PubMed ID: 17766169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of tumor angiogenesis by targeting endothelial surface ATP synthase with sangivamycin.
    Komi Y; Ohno O; Suzuki Y; Shimamura M; Shimokado K; Umezawa K; Kojima S
    Jpn J Clin Oncol; 2007 Nov; 37(11):867-73. PubMed ID: 17956898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial cell response to lactate: implication of PAR modification of VEGF.
    Kumar VB; Viji RI; Kiran MS; Sudhakaran PR
    J Cell Physiol; 2007 May; 211(2):477-85. PubMed ID: 17167776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor-alpha receptor p75 is required in ischemia-induced neovascularization.
    Goukassian DA; Qin G; Dolan C; Murayama T; Silver M; Curry C; Eaton E; Luedemann C; Ma H; Asahara T; Zak V; Mehta S; Burg A; Thorne T; Kishore R; Losordo DW
    Circulation; 2007 Feb; 115(6):752-62. PubMed ID: 17261656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic neovascularization by nanotechnology-mediated cell-selective delivery of pitavastatin into the vascular endothelium.
    Kubo M; Egashira K; Inoue T; Koga J; Oda S; Chen L; Nakano K; Matoba T; Kawashima Y; Hara K; Tsujimoto H; Sueishi K; Tominaga R; Sunagawa K
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):796-801. PubMed ID: 19325146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.